We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
51 hedge funds and large institutions have $127M invested in scPharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 51 → 51 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
1% less capital invested
Capital invested by funds: $129M → $127M (-$1.72M)
2.89% less ownership
Funds ownership: 65.46% → 62.57% (-2.9%)
Holders
51
Holders Change
–
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
17
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Northern Trust
Chicago,
Illinois
|
+$290K |
| 2 |
Two Sigma Investments
New York
|
+$206K |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$184K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$140K |
| 5 |
Goldman Sachs
New York
|
+$129K |
